Version 1
: Received: 12 May 2021 / Approved: 13 May 2021 / Online: 13 May 2021 (15:26:34 CEST)
How to cite:
Naseri, A.; Seyedi Sahebari, S.; Hosseini, M. Pharmacotherapy of COVID-19: Considerations for Pregnancy and Breastfeeding. Preprints2021, 2021050311. https://doi.org/10.20944/preprints202105.0311.v1
Naseri, A.; Seyedi Sahebari, S.; Hosseini, M. Pharmacotherapy of COVID-19: Considerations for Pregnancy and Breastfeeding. Preprints 2021, 2021050311. https://doi.org/10.20944/preprints202105.0311.v1
Naseri, A.; Seyedi Sahebari, S.; Hosseini, M. Pharmacotherapy of COVID-19: Considerations for Pregnancy and Breastfeeding. Preprints2021, 2021050311. https://doi.org/10.20944/preprints202105.0311.v1
APA Style
Naseri, A., Seyedi Sahebari, S., & Hosseini, M. (2021). Pharmacotherapy of COVID-19: Considerations for Pregnancy and Breastfeeding. Preprints. https://doi.org/10.20944/preprints202105.0311.v1
Chicago/Turabian Style
Naseri, A., Sepideh Seyedi Sahebari and Mohammad-Salar Hosseini. 2021 "Pharmacotherapy of COVID-19: Considerations for Pregnancy and Breastfeeding" Preprints. https://doi.org/10.20944/preprints202105.0311.v1
Abstract
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become the chief concern of the international community in almost no time. As of May 9th, 2021, more than 150 million cases and 3.2 million deaths have been recorded. Considering the early struggle in treating COVID-19 patients, the researchers and clinicians have decided to try the previously available drugs according to their mechanisms of action. Hence, many antivirals, antibiotics, antiparasitics, and antipyretics have been proposed. Pregnant women, fetuses, and infants are known high-risk populations that are threatened during disease outbreaks. Therefore, this article reviews the safety of potential drugs for COVID-19 patients during pregnancy and breastfeeding.
Keywords
Angiotensin converting enzyme 2; breast feeding; drug therapy; pregnancy; severe acute respiratory syndrome coronavirus 2
Subject
Medicine and Pharmacology, Immunology and Allergy
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Commenter:
The commenter has declared there is no conflict of interests.